• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Fat Tail Daily

Investment Ideas From the Edge of the Bell Curve

  • Menu
    • Commodities
      • Resources and Mining
      • Copper
      • Gold
      • Iron Ore
      • Lithium
      • Silver
      • Graphite
      • Rare Earths
    • Technology
      • AI
      • Bitcoin
      • Cryptocurrency
      • Energy
      • Financial Technology
      • Bio Technology
    • Market Analysis
      • Latest ASX News
      • Dividend Shares
      • ETFs
      • Stocks and Bonds
    • Macro
      • Australian Economy
      • Central Banks
      • World Markets
    • Small Caps
    • More
      • Investment Guides
      • Premium Research
      • Editors
      • About
      • Contact Us
  • Latest
  • Fat Tail Series
  • About Us
Technology Bio Tech

Creso Share Price Up — Launches New Cannabis Drug (ASX:CPH)

Like 0

By Ryan Clarkson-Ledward, Friday, 16 July 2021

Aussie pot stock Creso Pharma Ltd [ASX:CPH] shares are on the up today. The CPH Share Price is trading 8.89% higher on the news of the launch of Creso’s newest drug, cannaDOL...

Aussie pot stock Creso Pharma Ltd [ASX:CPH] share price is on the up today.

The CPH Share Price is trading 8.89% higher on the news of the launch of Creso’s newest drug, cannaDOL.

It’s the latest development from Creso, who has diversified their product and market offering several times in recent months. Even coming one day after the company announced the completion of its Halucenex takeover.

Which you can read all about in our coverage, right here.

For now, let’s talk about this new drug…

Chasing Swiss sports, health, and wellness

First and foremost, cannaDOL is a new type of cannabis gel. A drug that has been split into two distinctly different products: cannaDOL Boost and cannaDOL Recovery.

As you can probably guess, these two formulations offer different solutions.

Boost is designed to increase the energy of users with a mixture of hemp CBD, caffeine, taurine, vitamins, and minerals.

Recovery on the other hand is meant to soothe the patient. Using the same hemp CBD, vitamins, and minerals — but with added lemon balm and curcumin.

Together, Creso hopes to penetrate the Swiss sport, health, and wellness markets. Utilsing their established wholesaler network in Switzerland to sell these gels across pharmacies, drugstores, and sport/fitness centres.

As Commerical Director, Dr Gian Trepp comments:

‘The recent development of our ecommerce channel and new products formulations is a very pleasing development and we are proud to substantially strengthen our sport products portfolio with cannaDOL Boost and Recovery.

‘Recent initiatives will assist the Company to expand its leading presence in the Swiss and European sports markets, which provide another high yield and low risk opportunity for the Company. Discussions with additional partners and specialty retailers are ongoing and we anticipate that further growth can be achieved across Europe and more broadly.’

For shareholders it’s now a matter of waiting to see just how popular cannaDOL will be.

Because while Creso has plenty of interesting developments, they have yet to really strike gold. But perhaps this new gel could be the breakthrough they need.

What’s next for the Creso Share Price?

Beyond cannaDOL, Creso has a lot going on behind the scenes.

As I mentioned earlier, the finalisation of the Halucenex takeover is a big development. One that has pivoted this local pot stock into the exciting but risky field of psychedelic medicines.

A sector that is rapidly engaging with and experimenting with other illicit drugs for newfound medicinal uses. Something that has attracted a lot of interest from a small subset of biotech firms in Canada, in particular. Which is exactly where Halucenex is based.

So, for investors, there is a lot of exciting potential possibly to come.

It’s simply a matter of waiting and watching for further updates.

In the meantime, if you’re looking for more pot stock ideas, we can help. Our cannabis investment report will tell you all you need to know about this fascinating industry. Not to mention three names of our favourite pot stocks to consider investing in right now.

Get your copy of the full report, for free, right here.

Regards,

Ryan Clarkson-Ledward,
For Money Morning

PS: Our publication Money Morning is a fantastic place to start on your investment journey. We talk about the big trends driving the most innovative stocks on the ASX. Learn all about it here

All advice is general advice and has not taken into account your personal circumstances.

Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

Ryan Clarkson-Ledward

Ryan’s Premium Subscriptions

Publication logo
Fat Tail Investment Research

Latest Articles

  • Australia ain’t the USA…and that’s great!
    By Callum Newman

    The outlook for Australia and the ASX are very different to the US and US shares. Here’s why…

  • The biggest infrastructure spending boom in history just kicked off
    By Nick Hubble

    Did governments screw up our gas supply? According to some sources in the industry, a rather similar thing happened to our electricity and water industry.

  • You Read it Here First: Great Asset Rotation Underway
    By James Cooper

    Media is swirling on the great asset transition taking place from the banks to the miners. But James Cooper made this prediction months ago in Mining Memo. Are you taking advantage?

Primary Sidebar

Latest Articles

  • Australia ain’t the USA…and that’s great!
  • The biggest infrastructure spending boom in history just kicked off
  • You Read it Here First: Great Asset Rotation Underway
  • The sector primed to fly into 2026
  • OpenAI and Microsoft Divorce?: Why this could be good for you

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2025 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988